We invent novel drugs for patients with autoimmune disease.

I’m proud of our team. We continue to invent and advance immune modulating drug candidates for the benefit of patients. Autoimmune disease patients need us to be creative and focused on novel scientific approaches.

We are nimble. We collaborate. We persevere.

We partner with highly skilled people outside the company, both in academia and industry, who keep advancing our collective technical level. We persevere through challenges until we get it right.

We are resolved to make a difference for individuals living with autoimmune diseases and are thankful for the confidence entrusted in us by our investors.

David S. Block
CEO, Gliknik Inc.